keyword
https://read.qxmd.com/read/38606091/cd20-t-cells-in-monoclonal-b-cell-lymphocytosis-and-chronic-lymphocytic-leukemia-frequency-phenotype-and-association-with-disease-progression
#1
JOURNAL ARTICLE
Cristiana Rodrigues, Paula Laranjeira, Aryane Pinho, Isabel Silva, Sandra Silva, Margarida Coucelo, Ana Catarina Oliveira, Ana Teresa Simões, Inês Damásio, Helena Matos Silva, Mafalda Urbano, Ana Bela Sarmento-Ribeiro, Catarina Geraldes, M Rosário Domingues, Julia Almeida, Ignacio Criado, Alberto Orfao, Artur Paiva
INTRODUCTION: In monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL), the expansion of malignant B cells disrupts the normal homeostasis and interactions between B cells and T cells, leading to immune dysregulation. CD20+ T cells are a subpopulation of T cells that appear to be involved in autoimmune diseases and cancer. METHODS: Here, we quantified and phenotypically characterized CD20+ T cells from MBL subjects and CLL patients using flow cytometry and correlated our findings with the B-cell receptor mutational status and other features of the disease...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38455700/giant-cell-arteritis-presenting-as-multiple-ischaemic-strokes-a-successful-case-of-endovascular-treatment
#2
JOURNAL ARTICLE
Ana Órfão, Carolina Saca, Inês Alexandre, Ana Maria Oliveira, João Fernandes Serôdio, João Barreira, Teresa Mesquita
UNLABELLED: Giant cell arteritis (GCA) may manifest with aggressive intracranial stenosis resistant to medical therapy, and patients may develop refractory neurologic deficits and cerebral infarcts, making GCA a life-threatening condition. We report the case of a 68-year-old woman recently diagnosed with GCA, medicated with prednisolone 60 mg daily. Two weeks later, the patient was admitted to our Stroke Unit after a sudden episode of global aphasia. Magnetic resonance angiography showed two recent ischaemic lesions, besides an erythrocyte sedimentation rate of 17 mm/hour...
2024: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38405932/cabergoline-as-a-novel-strategy-for-post-pregnancy-breast-cancer-prevention-in-mice-and-human
#3
Natalia García-Sancha, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Oriol Cunillera Puértolas, Mercè Marzo-Castillejo, Sonia Castillo-Lluva, Diego Alonso-López, Javier De Las Rivas, Julio Pozo, Alberto Orfao, Luis Valero-Juan, Carmen Patino-Alonso, David Perera, Ashok R Venkitaraman, Jian-Hua Mao, Hang Chang, Marina Mendiburu-Eliçabe, Patricia González-García, Eduardo Caleiras, Isabel Peset, María Begoña García Cenador, Francisco Javier García-Criado, Jesús Pérez-Losada
Post-pregnancy breast cancer often carries a poor prognosis, posing a major clinical challenge. The increasing trend of later-life pregnancies exacerbates this risk, highlighting the need for effective chemoprevention strategies. Current options, limited to selective estrogen receptor modulators, aromatase inhibitors, or surgical procedures, offer limited efficacy and considerable side effects. Here, we report that cabergoline, a dopaminergic agonist, reduces the risk of breast cancer post-pregnancy in a Brca1/P53 -deficient mouse model, with implications for human breast cancer prevention...
February 5, 2024: Research Square
https://read.qxmd.com/read/38354852/vertical-dorsal-rhinotomy-in-pediatric-nasal-dermoid-surgery
#4
Pedro L Alexandre, Gil Coutinho, Tiago Órfão, Pedro Marques, Jorge Spratley, Carla Pinto Moura
INTRODUCTION AND OBJECTIVES: Nasal dermoids are uncommon midline congenital lesions in the nose, usually diagnosed in the first years of life. Imaging is mandatory to evaluate local and intracranial extension and treatment consists in surgical excision. This study aims to review the experience of the department in managing pediatric nasal dermoids using a dorsal rhinotomy surgical approach. MATERIAL AND METHODS: Retrospective case series of pediatric nasal dermoids treated at a tertiary university teaching hospital over a period of seven years...
February 12, 2024: Acta otorrinolaringologica española
https://read.qxmd.com/read/38354229/engineered-t-cells-secreting-anti-bcma-t-cell-engagers-control-multiple-myeloma-and-promote-immune-memory-in-vivo
#5
JOURNAL ARTICLE
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Óscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francesc Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Río, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martín-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Álvarez-Vallina
Multiple myeloma is the second most common hematological malignancy in adults and remains an incurable disease. B cell maturation antigen (BCMA)-directed immunotherapy, including T cells bearing chimeric antigen receptors (CARs) and systemically injected bispecific T cell engagers (TCEs), has shown remarkable clinical activity, and several products have received market approval. However, despite promising results, most patients eventually become refractory and relapse, highlighting the need for alternative strategies...
February 14, 2024: Science Translational Medicine
https://read.qxmd.com/read/38299742/t-cell-immune-profile-in-blood-of-systemic-mastocytosis-association-with-disease-features
#6
JOURNAL ARTICLE
Alba Pérez-Pons, Cristina Teodosio, María Jara-Acevedo, Ana Henriques, Paula Navarro-Navarro, Andrés C García-Montero, Iván Álvarez-Twose, Quentin Lecrevisse, Rafael Fluxa, Laura Sánchez-Muñoz, Carolina Caldas, Julio Pozo, Silvia Martín, Teresa Contreras Sanfeliciano, Carlos E Pedreira, Vitor Botafogo, Oscar González-López, Andrea Mayado, Alberto Orfao
BACKGROUND: Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT-mutated mast cells (MC). KIT-mutated MC display activated features and release MC mediators that might act on the tumour microenvironment and other immune cells. Here, we investigated the distribution of lymphocyte subsets in blood of patients with distinct subtypes of SM and determined its association with other disease features. METHODS: We studied the distribution of TCD4+ and TCD4- cytotoxic cells and their subsets, as well as total NK- and B cells, in blood of 115 SM patients-38 bone marrow mastocytosis (BMM), 67 indolent SM (ISM), 10 aggressive SM (ASM)- and 83 age-matched healthy donors (HD), using spectral flow cytometry and the EuroFlow Immunomonitoring panel, and correlated it with multilineage KITD816V , the alpha-tryptasemia genotype (HαT) and the clinical manifestations of the disease...
February 1, 2024: Allergy
https://read.qxmd.com/read/38072838/immunophenotypic-assessment-of-clonal-plasma-cells-and-b-cells-in-bone-marrow-and-blood-in-the-diagnostic-classification-of-early-stage-monoclonal-gammopathies-an-istopmm-study
#7
JOURNAL ARTICLE
Oihane Pérez-Escurza, Juan Flores-Montero, Jón Þórir Óskarsson, Luzalba Sanoja-Flores, Julio Del Pozo, Quentin Lecrevisse, Silvia Martín, Elín Ruth Reed, Guðlaug Katrín Hákonardóttir, Stephen Harding, Sigrún Þorsteinsdóttir, Sæmundur Rögnvaldsson, Thorvardur Jon Love, Brian Durie, Sigurður Yngvi Kristinsson, Alberto Orfao
Monoclonal gammopathy of undetermined significance (MGUS) is the earliest discernible stage of multiple myeloma (MM) and Waldenström's macroglobulinemia (WM). Early diagnosis of MG may be compromised by the low-level infiltration, undetectable to low-sensitive methodologies. Here, we investigated the prevalence and immunophenotypic profile of clonal (c) plasma cells (PC) and/or cB-lymphocytes in bone marrow (BM) and blood of subjects with a serum M-component from the iSTOPMM program, using high-sensitive next-generation flow cytometry (NGF), and its utility in the diagnostic classification of early-stage MG...
December 11, 2023: Blood Cancer Journal
https://read.qxmd.com/read/38048552/predictors-of-unsustained-measurable-residual-disease-negativity-in-transplant-eligible-multiple-myeloma-patients
#8
JOURNAL ARTICLE
Camila Guerrero, Noemi Puig, María-Teresa Cedena, María José Calasanz, Norma C Gutierrez, Manuela Fernandez, Albert Oriol, Rafael Ríos-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, M V Mateos, Joaquin Martinez-Lopez, Laura Rosiñol, Joan Bladé, Juan-Jose Lahuerta, Jesus San-Miguel, Bruno Paiva
The role of measurable residual disease (MRD) negativity as a biomarker to stop treatment is being investigated in transplant-eligible multiple myeloma (MM). Thus, it is important to identify risk factors of MRD resurgence and/or progressive disease (PD) among patients achieving undetectable MRD in order to avoid undertreating them. Here, we studied 267 newly-diagnosed transplant-eligible MM patients enrolled in the GEM2012MENOS65 and GEM2014MAIN clinical trials who achieved MRD negativity by next-generation flow cytometry...
December 4, 2023: Blood
https://read.qxmd.com/read/38040702/determining-hemodilution-in-diagnostic-bone-marrow-aspirated-samples-in-plasma-cell-disorders-by-next-generation-flow-cytometry-proposal-for-a-bone-marrow-quality-index
#9
JOURNAL ARTICLE
Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Thor Aspelund, Steinar Bragi Gunnarsson, Guðlaug Katrín Hákonardóttir, Guðrún Ásta Sigurðardóttir, Ásdís Rósa Þórðardóttir, Gauti Kjartan Gíslason, Andri Ólafsson, Jón Kristinn Sigurðsson, Elías Eyþórsson, Ásbjörn Jónsson, Brynjar Viðarsson, Páll Torfi Önundarson, Bjarni A Agnarsson, Róbert Pálmason, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Stephen Harding, Juan Flores-Montero, Alberto Orfao, Brian G M Durie, Thorvardur Jon Love, Sigurdur Yngvi Kristinsson
Hemodilution of bone marrow (BM) aspirates is a limitation of multiparameter flow cytometry (MFC) in plasma cell disorders. There is a need for a validated approach for assessing sample quality and the distribution of non-plasma cell BM populations by MFC could provide a solution. We evaluated BM-associated cell populations, assessed by next-generation flow cytometry (NGF) and white blood cell (WBC) count in 351 BM aspirated samples from 219 participants with plasma cell disorders in the Iceland Screens, Treats, or Prevents MM study (iStopMM), as markers of hemodilution by their discriminatory ability between first and (generally more hemodiluted) second pull BM aspirated samples...
December 1, 2023: Blood Cancer Journal
https://read.qxmd.com/read/38035080/in-depth-blood-immune-profiling-of-good-syndrome-patients
#10
JOURNAL ARTICLE
Alba Torres-Valle, Larraitz Aragon, Susana L Silva, Cristina Serrano, Miguel Marcos, Josefa Melero, Carolien Bonroy, Pedro Pablo Arenas-Caro, David Monzon Casado, Pedro Mikel Requejo Olaizola, Jana Neirinck, Mattias Hofmans, Sonia de Arriba, María Jara, Carlos Prieto, Ana E Sousa, Álvaro Prada, Jacques J M van Dongen, Martín Pérez-Andrés, Alberto Orfao
INTRODUCTION: Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered by the lack of data about the underlying immune alterations, a controversy existing on whether it is a unique diagnostic entity vs . a subtype of Common Variable Immune Deficiency (CVID)...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38022341/one-size-does-not-fit-all-medication-reconciliation-and-review-at-the-hospital-at-home
#11
JOURNAL ARTICLE
Daniela Madeira, Flávia Baduy, Ana Orfão, Clara Matos, Rui Osório, Ana C Brito
Mistakes in the medication process are frequent and a common cause of morbidity and mortality. Medication reconciliation (MRec) and medication review (MRev) are the processes of creating the most accurate medication list and adapting it to optimize the effectiveness of medicines and minimize adverse effects. This is crucial in all stages of medical care, especially at discharge. The present study aims to evaluate and describe the process of MRec and MRev, with a focus on deprescribing, that we conduct at the Hospital at Home...
October 2023: Curēus
https://read.qxmd.com/read/37915569/automated-euroflow-approach-for-standardized-in-depth-dissection-of-human-circulating-b-cells-and-plasma-cells
#12
JOURNAL ARTICLE
Alejandro H Delgado, Rafael Fluxa, Martin Perez-Andres, Annieck M Diks, Jacqueline A M van Gaans-van den Brink, Alex-Mikael Barkoff, Elena Blanco, Alba Torres-Valle, Magdalena A Berkowska, Georgiana Grigore, J J M van Dongen, Alberto Orfao
BACKGROUND: Multiparameter flow cytometry (FC) immunophenotyping is a key tool for detailed identification and characterization of human blood leucocytes, including B-lymphocytes and plasma cells (PC). However, currently used conventional data analysis strategies require extensive expertise, are time consuming, and show limited reproducibility. OBJECTIVE: Here, we designed, constructed and validated an automated database-guided gating and identification (AGI) approach for fast and standardized in-depth dissection of B-lymphocyte and PC populations in human blood...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37894806/antibody-based-and-cell-therapies-for-advanced-mastocytosis-established-and-novel-concepts
#13
REVIEW
Peter Valent, Cem Akin, Michel Arock, Karoline V Gleixner, Hildegard Greinix, Olivier Hermine, Hans-Peter Horny, Daniel Ivanov, Alberto Orfao, Werner Rabitsch, Andreas Reiter, Axel Schulenburg, Karl Sotlar, Wolfgang R Sperr, Celalettin Ustun
Advanced systemic mastocytosis (SM) is a heterogeneous group of myeloid neoplasms characterized by an uncontrolled expansion of mast cells (MC) in one or more internal organs, SM-induced tissue damage, and poor prognosis. Advanced SM can be categorized into aggressive SM (ASM), MC leukemia (MCL), and SM with an associated hematologic neoplasm (SM-AHN). In a vast majority of all patients, neoplastic cells display a KIT mutation, mostly D816V and rarely other KIT variants. Additional mutations in other target genes, such as SRSF2 , ASXL1 , or RUNX1 , may also be identified, especially when an AHN is present...
October 12, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37818990/clinical-impact-of-the-tpsab1-genotype-in-mast-cell-diseases-a-rema-study-in-a-cohort-of-959-individuals
#14
JOURNAL ARTICLE
David González-de-Olano, Paula Navarro-Navarro, Javier I Muñoz-González, Laura Sánchez-Muñoz, Ana Henriques, Ana de-Andrés-Martín, Dolores Peralta-Arjonilla, Andrea Mayado, María Jara-Acevedo, Andrés C García-Montero, Alberto Orfao, Iván Álvarez-Twose
BACKGROUND: A close association between hereditary alpha-tryptasemia (HAT) and mast cell (MC) disorders has been previously reported. However, the relationship between HAT and the diagnostic subtypes and clinical features of MC disorders still remains to be established. OBJECTIVE: To determine the prevalence of HAT in healthy donors (HD) vs patients with different diagnostic subtypes of MC activation syndromes (MCAS) and mastocytosis, and its relationship with the clinical behavior of the disease...
October 11, 2023: Allergy
https://read.qxmd.com/read/37809153/fat-embolism-a-rare-complication-of-bone-biopsy
#15
Daniela Madeira, Ana Orfão, Clara Matos, Patrícia Vasconcelos
We report a woman who was admitted to the hospital with a sudden onset of extensive maculopapular erythematous rash involving the trunk and extremities, six weeks after initiating antihypertensive medication. She had atypical lymphocytosis with Gumprecht shadows, elevated liver enzymes, and acute kidney injury. The diagnosis of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antihypertensive drugs was suspected and the antihypertensive drugs were suspended. A hypothesis of lymphoproliferative disease was also considered, and consequently, a myelogram and bone biopsy of the iliac crest were performed...
September 2023: Curēus
https://read.qxmd.com/read/37799214/gabapentin-induced-cutaneous-leukocytoclastic-vasculitis-a-case-report
#16
Ana Órfão, Daniela Madeira, Daniel Maia Duarte, Filipa Galante Pereira, Clara Matos
Leukocytoclastic vasculitis (LCV) is a type of small vessel vasculitis, characterized by a perivascular neutrophilic inflammatory infiltrate with fibrinoid necrosis and fragmentation of nuclei ("leukocytoclasia"). Although up to half of the cases of LCV are idiopathic, infections and drugs are the most common secondary triggers for this condition. We present the case of an 88-year-old woman who developed an erythematous maculopapular rash on both thighs three days after starting gabapentin for neuropathic leg pain, without other associated symptoms...
September 2023: Curēus
https://read.qxmd.com/read/37792579/immune-cell-kinetics-and-antibody-response-in-covid-19-patients-with-low-count-monoclonal-b-cell-lymphocytosis
#17
JOURNAL ARTICLE
Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Quentin Lecrevisse, Cristina Carbonell, Alba Pérez-Pons, Alba Torres-Valle, Julio Pozo, José Ángel Martín-Oterino, Óscar González-López, Amparo López-Bernús, Marta Bernal-Ribes, Moncef Belhassen-García, Oihane Pérez-Escurza, Martín Pérez-Andrés, Lourdes Vazquez, Guillermo Hernández-Pérez, Francisco Javier García Palomo, Pilar Leoz, Pilar Costa-Alba, Elena Pérez-Losada, Ana Yeguas, Miryam Santos Sánchez, Marta García-Blázquez, F Javier Morán-Plata, Daniela Damasceno, Vitor Botafogo, Noemí Muñoz-García, Rafael Fluxa, Jacques J M van Dongen, Miguel Marcos, Julia Almeida, Alberto Orfao
Low-count monoclonal B-cell lymphocytosis (MBLlo ) has been associated with an underlying immunodeficiency and has recently emerged as a new risk factor for severe COVID-19. Here, we investigated the kinetics of immune cell and antibody responses in blood during COVID-19 of MBLlo versus non-MBL patients. For this study, we analyzed the kinetics of immune cells in blood of 336 COVID-19 patients (74 MBLlo and 262 non-MBL), who had not been vaccinated against SARS-CoV-2, over a period of 43 weeks since the onset of infection, using high-sensitivity flow cytometry...
October 4, 2023: American Journal of Hematology
https://read.qxmd.com/read/37760011/predominantly-pro-inflammatory-phenotype-with-mixed-m1-m2-polarization-of-peripheral-blood-classical-monocytes-and-monocyte-derived-macrophages-among-patients-with-excessive-ethanol-intake
#18
JOURNAL ARTICLE
María Fernández-Regueras, Cristina Carbonell, Daniel Salete-Granado, Juan-Luis García, Marcos Gragera, María-Ángeles Pérez-Nieto, Francisco-Javier Morán-Plata, Andrea Mayado, Jorge-Luis Torres, Luis-Antonio Corchete, Ricardo Usategui-Martín, Elena Bueno-Martínez, Maura Rojas-Pirela, Guadalupe Sabio, Rogelio González-Sarmiento, Alberto Orfao, Francisco-Javier Laso, Julia Almeida, Miguel Marcos
Excessive alcohol consumption impairs the immune system, induces oxidative stress, and triggers the activation of peripheral blood (PB) monocytes, thereby contributing to alcoholic liver disease (ALD). We analyzed the M1/M2 phenotypes of circulating classical monocytes and macrophage-derived monocytes (MDMs) in excessive alcohol drinkers (EADs). PB samples from 20 EADs and 22 healthy controls were collected for isolation of CD14+ monocytes and short-term culture with LPS/IFNγ, IL4/IL13, or without stimulation...
September 1, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/37740440/minimal-residual-disease-assessment-in-b-cell-precursor-acute-lymphoblastic-leukemia-by-semi-automated-identification-of-normal-hematopoietic-cells-a-euroflow-study
#19
JOURNAL ARTICLE
Martijn W C Verbeek, Beatriz Soriano Rodríguez, Lukasz Sedek, Anna Laqua, Chiara Buracchi, Malicorne Buysse, Michaela Reiterová, Elen Oliveira, Daniela Morf, Sjoerd R Oude Alink, Susana Barrena, Saskia Kohlscheen, Stefan Nierkens, Mattias Hofmans, Paula Fernandez, Elaine Sobral de Costa, Ester Mejstrikova, Tomasz Szczepanski, Lukasz Slota, Monika Brüggemann, Giuseppe Gaipa, Georgiana Grigore, Jacques J M van Dongen, Alberto Orfao, Vincent H J van der Velden
Presence of minimal residual disease (MRD), detected by flow cytometry, is an important prognostic biomarker in the management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, data-analysis remains mainly expert-dependent. In this study, we designed and validated an Automated Gating & Identification (AGI) tool for MRD analysis in BCP-ALL patients using the two tubes of the EuroFlow 8-color MRD panel. The accuracy, repeatability, and reproducibility of the AGI tool was validated in a multicenter study using bone marrow follow-up samples from 174 BCP-ALL patients, stained with the EuroFlow BCP-ALL MRD panel...
September 22, 2023: Cytometry. Part B, Clinical Cytometry
https://read.qxmd.com/read/37730678/large-t-cell-clones-expressing-immune-checkpoints-increase-during-multiple-myeloma-evolution-and-predict-treatment-resistance
#20
JOURNAL ARTICLE
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, Maria-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco S Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios Tamayo, Jose-Maria Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosiñol, Juan-José Lahuerta, Joan Blade, Maria-Victoria Mateos, Jesús F San-Miguel, Jose-Angel Martinez Climent, Bruno Paiva
Tumor recognition by T cells is essential for antitumor immunity. A comprehensive characterization of T cell diversity may be key to understanding the success of immunomodulatory drugs and failure of PD-1 blockade in tumors such as multiple myeloma (MM). Here, we use single-cell RNA and T cell receptor sequencing to characterize bone marrow T cells from healthy adults (n = 4) and patients with precursor (n = 8) and full-blown MM (n = 10). Large T cell clones from patients with MM expressed multiple immune checkpoints, suggesting a potentially dysfunctional phenotype...
September 20, 2023: Nature Communications
keyword
keyword
37622
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.